InsiderClue
← All stocks

Edgewise Therapeutics, Inc.

EWTX Mostly scheduled
CIK 0001710072 #1406 in the set updated 18 Sep 2026
Bought (12 mo)
$199.40K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$19.50M
$506.73K on a plan · $18.71M straight out of an exercise
Sold at will
$290.37K
2 of 33 sales
Net
−$19.30M
−$90.96K against sales at will

By person

11 insiders · 34 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Russell Alan J
Chief Scientific Officer
—
$10.25M (6) scheduled
−$10.25M
31,466
0.0290%
$1.37M
+84.8%
Donovan Joanne M.
CMO
—
$4.62M (11) scheduled
−$4.62M
8,625
0.0079%
$374.38K
−66.6%
Edris Badreddin
Director
—
$3.40M (5) scheduled
−$3.40M
19,820
0.0182%
$860.32K
0.0%
KOCH KEVIN
President and CEO
—
$785.04K (3) scheduled
−$785.04K
52,488
0.0483%
$2.28M
+262.5%
Derakhshan Behrad
Chief Business Officer
—
$223.42K (4) scheduled
−$223.42K
31,826
0.0293%
$1.38M
+89.0%
MOORE JOHN R
General Counsel
—
$219.82K (4) scheduled
−$219.82K
17,697
0.0163%
$768.16K
+444.2%
Fox Jonathan C
Director
$199.40K (1)
—
+$199.40K
24,833
0.0229%
$1.08M
+128.7%
Thompson Peter A.
Director
—
—
—
443,792
0.4086%
$19.26M
—
ORBIMED ADVISORS LLC entity
Director
—
—
—
443,792
0.4086%
$19.26M
—
Carruthers R Michael
Chief Financial Officer
—
—
—
86,162
0.0793%
$3.74M
+133.3%
Semigran Marc
Chief Development Officer
—
—
—
6,716
0.0062%
$291.52K
0.0%

Individual transactions

2
Insider
Date
Role
Action
Shares
Price
Amount
Donovan Joanne M.
27 Mar 2026
CMO
Sold on a plan
6,735
$30.98
$208.64K
Donovan Joanne M.
27 Mar 2026
CMO
Sold on a plan
9,623
$30.98
$298.10K
Show all 34 transactions →

What was left out

Form 4 filings counted 27
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 29
Sales at will 2
Transactions with no price 0
Shares from compensation/vesting 608,578
History held since 30 Mar 2021